Literature DB >> 11461082

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.

Y Miyasaka1, N Enomoto, K Nagayama, N Izumi, F Marumo, M Watanabe, C Sato.   

Abstract

The genetic basis of hepatocellular carcinoma (HCC) has not yet been fully understood. Although various methods have been developed to detect differentially expressed genes in malignant diseases, efficient analysis from clinical specimens is generally difficult to perform due to the requirement of a large amount of samples. In the present study, we analysed differentially expressed genes with a small amount of human HCC samples using suppression subtractive hybridization (SSH). Total RNA were obtained from the hepatitis C virus-associated HCC and adjacent non-HCC liver tissues. cDNA was synthesized using modified RT-PCR, and then tester cDNA was ligated with 2 different kinds of adaptors and hybridized with an excess amount of driver cDNA. Tester specific cDNA was obtained by suppression PCR and the final PCR product was subcloned and sequenced. We identified 7 known genes (focal adhesion kinase, deleted in colon cancer, guanine binding inhibitory protein alpha, glutamine synthetase, ornithine aminotransferase, M130, and pepsinogen C) and 2 previously unknown genes as being overexpressed in HCC, and 1 gene (decorin) as suppressed in HCC. Quantitative analysis of gene expression using quantitative RT-PCR demonstrated the differential expression of these genes in the original and other HCC samples. These findings demonstrated that it is possible to identify the previously unknown, differential gene expression from a small amount of clinical samples. Information about such alterations in gene expression could be useful for elucidating the genetic events in HCC pathogenesis, developing the new diagnostic markers, or determining novel therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461082      PMCID: PMC2364030          DOI: 10.1054/bjoc.2001.1901

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples.

Authors:  V Zachar; R A Thomas; A S Goustin
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

4.  Expression of retroviral sequences and oncogenes in murine hepatocellular tumors.

Authors:  T A Dragani; G Manenti; G Della Porta; S Gattoni-Celli; I B Weinstein
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

5.  Expression of focal adhesion kinase gene and invasive cancer.

Authors:  T M Weiner; E T Liu; R J Craven; W G Cance
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

6.  Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells.

Authors:  P Liang; L Averboukh; K Keyomarsi; R Sager; A B Pardee
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

7.  Unit-length line-1 transcripts in human teratocarcinoma cells.

Authors:  J Skowronski; T G Fanning; M F Singer
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

8.  Active LINE-1 retrotransposons in human testicular cancer.

Authors:  G L Bratthauer; T G Fanning
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

9.  Overexpression of glutamine synthetase in human primary liver cancer.

Authors:  L Christa; M T Simon; J P Flinois; R Gebhardt; C Brechot; C Lasserre
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

10.  Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.

Authors:  I Diez-Itza; A M Merino; J Tolivia; F Vizoso; L M Sánchez; C López-Otín
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

View more
  24 in total

1.  Construction and selection of subtracted cDNA library of mouse hepatocarcinoma cell lines with different lymphatic metastasis potential.

Authors:  Li Hou; Jan-Wu Tang; Xiao-Nan Cui; Bo Wang; Bo Song; Lei Sun
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers.

Authors:  Yi-Wen Chen; Hsiu-Chuan Chou; Ping-Chiang Lyu; Hsien-Sheng Yin; Fang-Liang Huang; Wun-Shaing Wayne Chang; Chiao-Yuan Fan; I-Fan Tu; Tzu-Chia Lai; Szu-Ting Lin; Ying-Chieh Lu; Chieh-Lin Wu; Shun-Hong Huang; Hong-Lin Chan
Journal:  Funct Integr Genomics       Date:  2011-01-19       Impact factor: 3.410

Review 3.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 4.  Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs.

Authors:  Hyunbeom Lee; Jose I Juncosa; Richard B Silverman
Journal:  Med Res Rev       Date:  2014-08-22       Impact factor: 12.944

5.  High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.

Authors:  Daraporn Chua-On; Tanakorn Proungvitaya; Anchalee Techasen; Temduang Limpaiboon; Sittiruk Roytrakul; Sopit Wongkham; Chaisiri Wongkham; Ongart Somintara; Sakkarn Sungkhamanon; Siriporn Proungvitaya
Journal:  Tumour Biol       Date:  2016-07-29

6.  Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.

Authors:  Romila Mascarenhas; Hoang V Le; Kenneth D Clevenger; Helaina J Lehrer; Dagmar Ringe; Neil L Kelleher; Richard B Silverman; Dali Liu
Journal:  Biochemistry       Date:  2017-09-06       Impact factor: 3.162

7.  Expression of liver cancer associated gene HCCA3.

Authors:  Z X Wang; G F Hu; H Y Wang; M C Wu
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

8.  Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

Authors:  Ehud Zigmond; Ami Ben Ya'acov; Hyunbeom Lee; Yoav Lichtenstein; Zvi Shalev; Yoav Smith; Lidya Zolotarov; Ehud Ziv; Rony Kalman; Hoang V Le; Hejun Lu; Richard B Silverman; Yaron Ilan
Journal:  ACS Med Chem Lett       Date:  2015-05-29       Impact factor: 4.345

9.  Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis.

Authors:  Kornélia Baghy; Zsolt Horváth; Eszter Regős; Katalin Kiss; Zsuzsa Schaff; Renato V Iozzo; Ilona Kovalszky
Journal:  FEBS J       Date:  2013-03-25       Impact factor: 5.542

10.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.